BSR: in my opinion, AMBS would not proactively push a market communication plan until all data from LP002 was in and multivariate numbers were crunched. For now, RUO market gets it when AMBS talks univariate, but the general market won't. So, I bet the multivariate and close to CLIA approval then the marketing machine will run. That being said, if they are going to spin it out then the marketing might be done by a partnering or buying company.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links